Gerd Horneff

13.1k total citations
324 papers, 5.5k citations indexed

About

Gerd Horneff is a scholar working on Hematology, Speech and Hearing and Rheumatology. According to data from OpenAlex, Gerd Horneff has authored 324 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Hematology, 133 papers in Speech and Hearing and 84 papers in Rheumatology. Recurrent topics in Gerd Horneff's work include Autoimmune and Inflammatory Disorders Research (226 papers), Adolescent and Pediatric Healthcare (130 papers) and Inflammasome and immune disorders (61 papers). Gerd Horneff is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (226 papers), Adolescent and Pediatric Healthcare (130 papers) and Inflammasome and immune disorders (61 papers). Gerd Horneff collaborates with scholars based in Germany, United States and Italy. Gerd Horneff's co-authors include Heinrike Schmeling, Ivan Foeldvari, Kirsten Minden, Ingrid Becker, Gerd Ganser, V. Wahn, Ariane Klein, Jens Klotsche, Tim Niehues and Martina Niewerth and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Gerd Horneff

288 papers receiving 5.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gerd Horneff 3.2k 1.6k 1.4k 1.4k 1.3k 324 5.5k
Anne‐Marie Prieur 4.1k 1.3× 1.9k 1.2× 1.6k 1.1× 2.2k 1.6× 1.8k 1.3× 55 6.6k
Andreas Reiff 2.4k 0.8× 982 0.6× 1.1k 0.7× 781 0.6× 1.8k 1.3× 68 4.0k
Pierre Quartier 3.1k 1.0× 3.4k 2.1× 795 0.6× 3.2k 2.3× 1.8k 1.4× 239 8.8k
Brigitte Bader‐Meunier 1.9k 0.6× 1.9k 1.2× 360 0.3× 1.6k 1.2× 1.8k 1.3× 212 5.8k
Isabelle Koné‐Paut 2.1k 0.7× 2.2k 1.4× 368 0.3× 2.9k 2.1× 1.5k 1.2× 201 6.1k
Alexei A. Grom 5.0k 1.6× 3.6k 2.2× 1.4k 1.0× 1.8k 1.3× 799 0.6× 122 7.4k
Sebastiaan J. Vastert 1.7k 0.5× 1.3k 0.8× 700 0.5× 889 0.7× 645 0.5× 124 3.4k
Athimalaipet V Ramanan 2.4k 0.7× 1.2k 0.7× 486 0.3× 595 0.4× 1.3k 1.0× 169 4.6k
Tomoyuki Imagawa 1.5k 0.5× 853 0.5× 501 0.3× 860 0.6× 718 0.5× 150 3.3k
Marilynn Punaro 1.2k 0.4× 3.2k 2.0× 374 0.3× 1.4k 1.0× 1.5k 1.1× 58 5.3k

Countries citing papers authored by Gerd Horneff

Since Specialization
Citations

This map shows the geographic impact of Gerd Horneff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Horneff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Horneff more than expected).

Fields of papers citing papers by Gerd Horneff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Horneff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Horneff. The network helps show where Gerd Horneff may publish in the future.

Co-authorship network of co-authors of Gerd Horneff

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Horneff. A scholar is included among the top collaborators of Gerd Horneff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Horneff. Gerd Horneff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brunner, Hermine I., Anna Shmagel, Gerd Horneff, et al.. (2024). Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial. Arthritis Care & Research. 77(5). 584–593. 4 indexed citations
2.
Horneff, Gerd, Daniel Windschall, Kirsten Minden, et al.. (2024). Vergleich der Therapie mit JAK-Inhibitoren bei der juvenilen idiopathischen Arthritis in der klinischen Praxis und in den Zulassungsstudien. Arthritis und Rheuma. 44(3). 190–198.
3.
Kuemmerle‐Deschner, Jasmin, Tilmann Kallinich, Jörg Henes, et al.. (2024). Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry. RMD Open. 10(1). e003890–e003890. 9 indexed citations
4.
5.
Kreuter, Alexander, Pia Moinzadeh, Maria Kinberger, et al.. (2024). S2k guideline: Diagnosis and therapy of localized scleroderma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(4). 605–620.
6.
Kreuter, Alexander, Pia Moinzadeh, Maria Kinberger, et al.. (2024). S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(4). 605–621. 1 indexed citations
7.
Shenoi, Susan, Gerd Horneff, Amita Aggarwal, & Angelo Ravelli. (2024). Treatment of non-systemic juvenile idiopathic arthritis. Nature Reviews Rheumatology. 20(3). 170–181. 9 indexed citations
8.
Klein, Ariane, Jasmin Kuemmerle‐Deschner, Frank Dressler, et al.. (2023). Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients—analysis of the BiKeR registry. Rheumatology International. 43(9). 1675–1684. 4 indexed citations
9.
Klein, Ariane & Gerd Horneff. (2023). Off-Label-Behandlung in der Kinderrheumatologie. Arthritis und Rheuma. 43(6). 411–417.
10.
Gerß, Joachim, Ariane Klein, Gerd Horneff, et al.. (2022). Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial. Annals of the Rheumatic Diseases. 81(7). 990–997. 19 indexed citations
11.
12.
Heiligenhaus, Arnd, Jens Klotsche, Martina Niewerth, et al.. (2020). Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany. Arthritis Research & Therapy. 22(1). 81–81. 18 indexed citations
13.
Quartier, Pierre, Е.I. Alexeeva, Tamás Constantin, et al.. (2020). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & Rheumatology. 73(2). 336–346. 23 indexed citations
14.
Horneff, Gerd, Ariane Klein, Prasad T. Oommen, et al.. (2017). Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry.. PubMed. 34(6). 1113–1120. 17 indexed citations
15.
Horneff, Gerd, Ivan Foeldvari, Ralf Trauzeddel, et al.. (2015). Induction and Maintenance of Remission By Etanercept in Enthesitis Related Arthritis JIA-Patients. RWTH Publications (RWTH Aachen). 67(10). 2417.
16.
Niewerth, Martina, Kirsten Minden, Jens Klotsche, & Gerd Horneff. (2014). Biologikatherapie der juvenilen idiopathische Arthritis im jungen Erwachsenenalter: Übergang von der pädiatrischen in die Erwachsenenversorgung. Zeitschrift für Rheumatologie. 73(6). 532–540. 1 indexed citations
17.
Horneff, Gerd, et al.. (2008). [Medical treatment of juvenile idiopathic arthritis].. PubMed. 31(9). 326–36; quiz 337. 4 indexed citations
18.
19.
Michels, H., Gerd Ganser, Guenther E. Dannecker, et al.. (2006). [Structural quality of rheumatology clinics for children and adolescents. Paper by a task force of the "Society of Pediatric and Adolescent Rheumatology" and of the "Association of Rheumatology Clinics in Germany"].. Zeitschrift für Rheumatologie. 65(4). 315. 11 indexed citations
20.
Michels, H., Gerd Ganser, Günther Dannecker, et al.. (2006). Strukturqualität von kinder- und jugendrheuma tologischen akutkliniken und - abteilungen : Projektgruppenarbeit der Gesellschaft für Kinder- und Jugendrheumatologie (GKIR) und des Verbandes Rheumatologischer Akutkliniken (VRA). Zeitschrift für Rheumatologie. 65(4). 315–326. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Marie Prieur Breakdown of academic impact, for papers by Andreas Reiff Breakdown of academic impact, for papers by Pierre Quartier Breakdown of academic impact, for papers by Brigitte Bader‐Meunier Breakdown of academic impact, for papers by Isabelle Koné‐Paut Breakdown of academic impact, for papers by Alexei A. Grom Breakdown of academic impact, for papers by Sebastiaan J. Vastert Breakdown of academic impact, for papers by Athimalaipet V Ramanan Breakdown of academic impact, for papers by Tomoyuki Imagawa Breakdown of academic impact, for papers by Marilynn Punaro
Rankless by CCL
2026